PDL BioPharma (PDLI) Announced Preclinical Data on HuLuc63 at the American Society of Hematology Annual Meeting
Tweet Send to a Friend
PDL BioPharma, Inc. (Nasdaq: PDLI) announced that preclinical data on HuLuc63, a humanized monoclonal antibody product targeting human CS1, were ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
